1. Home
  2. OLMA vs HLXB Comparison

OLMA vs HLXB Comparison

Compare OLMA & HLXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • HLXB
  • Stock Information
  • Founded
  • OLMA 2006
  • HLXB 2021
  • Country
  • OLMA United States
  • HLXB United States
  • Employees
  • OLMA N/A
  • HLXB N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • HLXB
  • Sector
  • OLMA Health Care
  • HLXB
  • Exchange
  • OLMA Nasdaq
  • HLXB NYSE
  • Market Cap
  • OLMA 299.7M
  • HLXB 255.2M
  • IPO Year
  • OLMA 2020
  • HLXB 2024
  • Fundamental
  • Price
  • OLMA $5.33
  • HLXB $10.43
  • Analyst Decision
  • OLMA Strong Buy
  • HLXB
  • Analyst Count
  • OLMA 4
  • HLXB 0
  • Target Price
  • OLMA $24.50
  • HLXB N/A
  • AVG Volume (30 Days)
  • OLMA 411.5K
  • HLXB 104.7K
  • Earning Date
  • OLMA 08-05-2025
  • HLXB 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • HLXB N/A
  • EPS Growth
  • OLMA N/A
  • HLXB N/A
  • EPS
  • OLMA N/A
  • HLXB 0.26
  • Revenue
  • OLMA N/A
  • HLXB N/A
  • Revenue This Year
  • OLMA N/A
  • HLXB N/A
  • Revenue Next Year
  • OLMA N/A
  • HLXB N/A
  • P/E Ratio
  • OLMA N/A
  • HLXB $41.55
  • Revenue Growth
  • OLMA N/A
  • HLXB N/A
  • 52 Week Low
  • OLMA $2.86
  • HLXB $10.28
  • 52 Week High
  • OLMA $16.62
  • HLXB $11.59
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.85
  • HLXB N/A
  • Support Level
  • OLMA $4.40
  • HLXB N/A
  • Resistance Level
  • OLMA $5.36
  • HLXB N/A
  • Average True Range (ATR)
  • OLMA 0.29
  • HLXB 0.00
  • MACD
  • OLMA 0.07
  • HLXB 0.00
  • Stochastic Oscillator
  • OLMA 93.20
  • HLXB 0.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About HLXB HELIX ACQUISITION CORP. II

Helix Acquisition Corp II is a Blank check company.

Share on Social Networks: